This report on global animal healthcare market studies the market in terms of various product types and their applicability on different animal species. Animal healthcare has been an area of interest for many pharmaceutical companies in the last few years due to the rise in global population and increasing demand for protein rich diet. It has become even more important because of greater instances of animal disease outbreaks coupled with large scale factory farming that requires high-quality animal feed additives, vaccines as well as hygiene management products.
For the purpose of this study, the various product types studied include (feed additives, pharmaceuticals and vaccines). Feed additives are further segmented as medicinal feed (minerals, vitamins and amino acids) and nutritional feed (enzymes, hormones, prebiotics and probiotics, immune modulators and feed acidifiers). Pharmaceuticals are further segmented as (endoparasiticides, ectoparasiticides, anti-inflammatories, and antibiotics). The animal types are segmented as (production animals and companion animals). The geographic segmentation of the global animal healthcare market is performed for the regions North America, Europe, Asia Pacific, Latin America and Middle East and Africa markets. The regions are also further sub-segmented on the basis of major countries.
This report also includes qualitative assessment factors such as market dynamics (drivers, restraints and opportunities) to have a good understanding of the current and anticipated trends in the global animal healthcare market. Competition assessment tools such as market attractiveness assessment and competitive landscape analysis by key players are also demonstrated in the study. Furthermore, this report concludes with profiling of key market players currently enjoying prominent position in the global animal healthcare market. The key players profiled in this report are Zoetis Inc., Merck & Co. Inc. (Intervet), Eli Lilly and Company (Elanco/Novartis), Bayer Healthcare AG, Ceva Sante Animale, Virbac SA, Vetoquinol SA, Boehringer Ingelheim GmbH, Nutreco N.V., Sanofi S.A. (MERIAL Limited), Cargill Inc. and Evonik Industires.
The global animal healthcare market is gaining momentum due to growth factors such as rising consumption of milk and meat around the globe, rising prevalence of zoonotic and food borne diseases and their transfer to human beings through consumption. Feed additives hold the largest market in the product segment due to swiftly growing animal population, increase in the number of factory farms to supplement agriculture. It is further segmented into nutritional feed which is given to production animals for their optimal growth and medicinal feed which is helpful to target and cure particular diseases. The pharmaceutical products will be the fastest growing market in the product segment due to increase in animal diseases such as (Bird flu, Brucellosis and Anthrax) and for curing reproductive problems. Overall, the global animal healthcare market is highly competitive with presence of multiple players like Zoetis, Inc. (Pfizer), Merck & Co., Inc. (Intervet), Eli Lilly and Company (Elanco/Novartis), Bayer Healthcare AG, Ceva Santé Animale, Virbac S.A, Vetoquinol SA specializing in respective fields. Consolidation activities are being increasingly witnessed on the competitive front with a view to increase the technological advancement in the production and R&D of feed additives, pharmaceuticals and vaccines for better animal health and available at low cost.
Animal healthcare has become of prime importance due to factors such as rising public awareness regarding animal health, increasing government expenditure to grow R&D for animal healthcare and increasing number of zoonotics. Currently the production animals hold the largest market in the animal type segment due to rise in milk and meat products and government initiatives to promote their rearing, which acts as additional source of income to poor farmers. Companion animals will be the fastest growing market in the animal type segment due to factors such as increased adoption of pet animals in the developing nations due to increased imitation of western culture and other lifestyle changes, they are used to guard property and the rise in animal bites has led to mandatory immunization of pet animals which also contribute to the overall growth of the global animal healthcare market.
North America was observed as the largest market for animal healthcare. According to the Centers for Disease Control and Prevention each year 3 out of every 4 emerging infectious disease in people are spread from animals. Children under the age of 5, pregnant women and geriatric population are at higher risk of serious illness from zoonotic diseases. The market growth is mainly attributed to increased population of animals, rising demand for protein rich diet (milk, meat and eggs) and rising incidence of animal diseases. Europe is expected to be the second largest market due to high awareness related to animal healthcare, and government grants to strengthen R&D facilities to promote animal reproduction and health. Growth of Asia Pacific market for animal healthcare is attributed to factors such as rising prevalence of zoonotics, competitive market due to manufactures involved in production of animal feed, medicines and vaccines, mandate for animal immunization by regulatory authorities and higher disposable income to keep pet/companion animals in this region. However, factors such as developing veterinary R&D, increasing public awareness regarding animal health and huge demand for Halal meat are going to fuel the rapid growth of animal healthcare market in Latin America and Middle East and Africa regions in the near future.
The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
This product will be delivered within 2 business days.
For the purpose of this study, the various product types studied include (feed additives, pharmaceuticals and vaccines). Feed additives are further segmented as medicinal feed (minerals, vitamins and amino acids) and nutritional feed (enzymes, hormones, prebiotics and probiotics, immune modulators and feed acidifiers). Pharmaceuticals are further segmented as (endoparasiticides, ectoparasiticides, anti-inflammatories, and antibiotics). The animal types are segmented as (production animals and companion animals). The geographic segmentation of the global animal healthcare market is performed for the regions North America, Europe, Asia Pacific, Latin America and Middle East and Africa markets. The regions are also further sub-segmented on the basis of major countries.
This report also includes qualitative assessment factors such as market dynamics (drivers, restraints and opportunities) to have a good understanding of the current and anticipated trends in the global animal healthcare market. Competition assessment tools such as market attractiveness assessment and competitive landscape analysis by key players are also demonstrated in the study. Furthermore, this report concludes with profiling of key market players currently enjoying prominent position in the global animal healthcare market. The key players profiled in this report are Zoetis Inc., Merck & Co. Inc. (Intervet), Eli Lilly and Company (Elanco/Novartis), Bayer Healthcare AG, Ceva Sante Animale, Virbac SA, Vetoquinol SA, Boehringer Ingelheim GmbH, Nutreco N.V., Sanofi S.A. (MERIAL Limited), Cargill Inc. and Evonik Industires.
The global animal healthcare market is gaining momentum due to growth factors such as rising consumption of milk and meat around the globe, rising prevalence of zoonotic and food borne diseases and their transfer to human beings through consumption. Feed additives hold the largest market in the product segment due to swiftly growing animal population, increase in the number of factory farms to supplement agriculture. It is further segmented into nutritional feed which is given to production animals for their optimal growth and medicinal feed which is helpful to target and cure particular diseases. The pharmaceutical products will be the fastest growing market in the product segment due to increase in animal diseases such as (Bird flu, Brucellosis and Anthrax) and for curing reproductive problems. Overall, the global animal healthcare market is highly competitive with presence of multiple players like Zoetis, Inc. (Pfizer), Merck & Co., Inc. (Intervet), Eli Lilly and Company (Elanco/Novartis), Bayer Healthcare AG, Ceva Santé Animale, Virbac S.A, Vetoquinol SA specializing in respective fields. Consolidation activities are being increasingly witnessed on the competitive front with a view to increase the technological advancement in the production and R&D of feed additives, pharmaceuticals and vaccines for better animal health and available at low cost.
Animal healthcare has become of prime importance due to factors such as rising public awareness regarding animal health, increasing government expenditure to grow R&D for animal healthcare and increasing number of zoonotics. Currently the production animals hold the largest market in the animal type segment due to rise in milk and meat products and government initiatives to promote their rearing, which acts as additional source of income to poor farmers. Companion animals will be the fastest growing market in the animal type segment due to factors such as increased adoption of pet animals in the developing nations due to increased imitation of western culture and other lifestyle changes, they are used to guard property and the rise in animal bites has led to mandatory immunization of pet animals which also contribute to the overall growth of the global animal healthcare market.
North America was observed as the largest market for animal healthcare. According to the Centers for Disease Control and Prevention each year 3 out of every 4 emerging infectious disease in people are spread from animals. Children under the age of 5, pregnant women and geriatric population are at higher risk of serious illness from zoonotic diseases. The market growth is mainly attributed to increased population of animals, rising demand for protein rich diet (milk, meat and eggs) and rising incidence of animal diseases. Europe is expected to be the second largest market due to high awareness related to animal healthcare, and government grants to strengthen R&D facilities to promote animal reproduction and health. Growth of Asia Pacific market for animal healthcare is attributed to factors such as rising prevalence of zoonotics, competitive market due to manufactures involved in production of animal feed, medicines and vaccines, mandate for animal immunization by regulatory authorities and higher disposable income to keep pet/companion animals in this region. However, factors such as developing veterinary R&D, increasing public awareness regarding animal health and huge demand for Halal meat are going to fuel the rapid growth of animal healthcare market in Latin America and Middle East and Africa regions in the near future.
Historical & Forecast Period
This study report represents analysis of each segment from 2020 to 2030 considering 2021 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2030.The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
Research Methodology
The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Animal Healthcare market are as follows:- Research and development budgets of manufacturers and government spending
- Revenues of key companies in the market segment
- Number of end users and consumption volume, price and value.
- Geographical revenues generate by countries considered in the report
- Micro and macro environment factors that are currently influencing the Animal Healthcare market and their expected impact during the forecast period.
Market Segmentation
Product
- Additive feed
- Medicinal feed additives
- Minerals
- Vitamins
- Amino acids
- Nutritional feed additives
- Enzymes
- Hormones
- Prebiotics and Probiotics
- Immune modulators
- Feed acidifiers
- Pharmaceuticals
- Ectoparasiticides
- Endoparasiticides
- Anti-inflammatories
- Antibiotics
- Vaccines
Animal
- Production animals
- Companion animals
Key questions answered in this report
- What are the key micro and macro environmental factors that are impacting the growth of Animal Healthcare market?
- What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
- Estimated forecast and market projections up to 2030.
- Which segment accounts for the fastest CAGR during the forecast period?
- Which market segment holds a larger market share and why?
- Are low and middle-income economies investing in the Animal Healthcare market?
- Which is the largest regional market for Animal Healthcare market?
- What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
- Which are the key trends driving Animal Healthcare market growth?
- Who are the key competitors and what are their key strategies to enhance their market presence in the Animal Healthcare market worldwide?
This product will be delivered within 2 business days.
Table of Contents
1. Preface
2. Executive Summary
3. Animal Healthcare Market: Business Outlook & Market Dynamics
4. Animal Healthcare Market: By Product, 2020-2030, USD (Million)
5. Animal Healthcare Market: By Animal, 2020-2030, USD (Million)
6. North America Animal Healthcare Market, 2020-2030, USD (Million)
7. UK and European Union Animal Healthcare Market, 2020-2030, USD (Million)
8. Asia Pacific Animal Healthcare Market, 2020-2030, USD (Million)
9. Latin America Animal Healthcare Market, 2020-2030, USD (Million)
10. Middle East and Africa Animal Healthcare Market, 2020-2030, USD (Million)
11. Company Profile
List of Figures
List of Tables
Companies Mentioned
- Bayer Healthcare AG
- Boehringer Ingelheim GmbH
- Cargill Inc.
- Ceva Sante Animale
- Eli Lilly and Company (Elanco/Novartis)
- Evonik Industries
- Merck & Co. Inc. (Intervet)
- Nutreco N.V.
- Sanofi S.A. (MERIAL Limited)
- Vetoquinol SA
- Virbac SA.
- Zoetis Inc. (Pfizer)